3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Neoplasms
5
Colorectal Neoplasms, Hereditary Nonpolyposis
3
Recurrence
2
Breast Neoplasms
2
Stage IIIb and IV Non Small Cell Lung Cancer
1
Solid Tumor, Adult
1
Rare Diseases
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Neuroblastoma
1
Neoplastic Syndromes, Hereditary
1
Neoplasm, Residual
1
Multiple Myeloma
1
Mouth Neoplasms
1
Microsatellite Instability
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Head and Neck Neoplasms
1
Genetic Predisposition to Disease
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Medullary
1
COVID-19
1
Biliary Tract Neoplasms
1
Adenocarcinoma of Lung
1
Interventions
Cyclophosphamide
82
Imatinib Mesylate
81
fludarabine phosphate
67
fludarabine
62
Whole-Body Irradiation
55
Mycophenolic Acid
54
Tacrolimus
42
nilotinib
40
Busulfan
39
Dasatinib
32
Cyclosporine
30
Peripheral Blood Stem Cell Transplantation
28
thymoglobulin
25
Melphalan
25
Thiotepa
24
Cytarabine
24
Granulocyte Colony-Stimulating Factor
23
Antilymphocyte Serum
23
Methotrexate
21
Filgrastim
21
Stem Cell Transplantation
20
ponatinib
16
Sirolimus
16
sargramostim
14
Cord Blood Stem Cell Transplantation
13
Rituximab
11
Cyclosporins
11
Clofarabine
11
venetoclax
10
peginterferon alfa-2b
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
High-Throughput Nucleotide Sequencing
×
Clear all
NCT05605379
2024-08-14
CML Piramid
University Hospital, Bordeaux
Recruiting
88 enrolled